Manulife amends its normal course issuer bid to repurchase for cancellation up to an additional 40 million of its common shares

C$ unless otherwise stated                             tsx/nyse/pse: mfc     sehk: 945 toronto , may 7, 2024 /prnewswire/ - manulife financial corporation ("manulife") announced today that the toronto stock exchange ("tsx") has approved manulife's amended normal course issuer bid ("ncib"). as previously announced, the purpose of the amendment is to increase the number of common shares that manulife may repurchase from up to 50 million (approximately 2.8% of shares outstanding) to up to 90 million (approximately 5% of shares outstanding as of february 12, 2024).
MFC Ratings Summary
MFC Quant Ranking